Resistant hypertension affects 1 in 10 with high BP, persisting despite multiple medications. Experts warn it needs early ...

Sotatercept drug may foster lung health in severe pulmonary hypertension patients, controlling pathological spread and ...

The U.S. Food and Drug Administration (FDA) approved sotatercept in March 2024 for treatment of pulmonary hypertension, ...

At Mandela University, a collaborative care model plays out in joint case discussions, school health screenings, mobile health truck outreach and even playground design projects with architecture ...

Is it safe to take blood pressure medication on an empty stomach? Learn how timing and food affect the safety and effectiveness of your BP meds.

Winrevair added to background therapy decreased the risk for clinical worsening in adults diagnosed with pulmonary arterial ...

The use of anticoagulants is not associated with improved overall survival in patients with pulmonary arterial hypertension, ...

DelveInsight’s report, “Chronic Pulmonary Hypertension Market Insights, Epidemiology, and Market Forecast-2034,” provides a ...

Hypertension causes an average of 123,300 deaths, with a staggering 1.5 million adults having uncontrolled hypertension in ...

Positive high-level results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic ...

Village Caregiving reports that aging in place brings hidden costs like home modifications, healthcare, and emergency ...

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...